Simplex Trading
KRYS icon

Simplex Trading’s Krystal Biotech KRYS Stock Holding History

Simplex Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Buy
400
+200
+100% +$53.2K ﹤0.01% 5042
2025
Q4 		$49.3K Sell
200
-900
-82% -$189K ﹤0.01% 5665
2025
Q3 		$194K Sell
1,100
-400
-27% -$59.9K ﹤0.01% 4972
2025
Q2 		$206K Buy
1,500
+1,400
+1,400% +$206K ﹤0.01% 4466
2025
Q1 		$18K Sell
100
-1,600
-94% -$269K ﹤0.01% 6659
2024
Q4 		$266K Sell
1,700
-2,800
-62% -$497K ﹤0.01% 4203
2024
Q3 		$819K Buy
4,500
+1,700
+61% +$328K ﹤0.01% 3105
2024
Q2 		$514K Sell
2,800
-10,600
-79% -$1.78M ﹤0.01% 3637
2024
Q1 		$2.38M Buy
13,400
+6,400
+91% +$889K ﹤0.01% 2232
2023
Q4 		$868K Buy
7,000
+4,300
+159% +$477K ﹤0.01% 3140
2023
Q3 		$313K Sell
2,700
-3,100
-53% -$378K ﹤0.01% 3896
2023
Q2 		$680K Sell
5,800
-9,500
-62% -$970K ﹤0.01% 2987
2023
Q1 		$1.22M Buy
15,300
+13,300
+665% +$1.04M ﹤0.01% 2399
2022
Q4 		$158K Buy
2,000
+1,000
+100% +$74.2K ﹤0.01% 4523
2022
Q3 		$69K Sell
1,000
-200
-17% -$14.4K ﹤0.01% 6005
2022
Q2 		$78K Sell
1,200
-600
-33% -$37.3K ﹤0.01% 5906
2022
Q1 		$119K Sell
1,800
-6,000
-77% -$375K ﹤0.01% 5905
2021
Q4 		$545K Sell
7,800
-23,700
-75% -$1.38M ﹤0.01% 3673
2021
Q3 		$2.26M Hold
31,500
– – ﹤0.01% 1991
2021
Q2 		$2.14M Buy
+31,500
New +$2.2M ﹤0.01% 2072
2020
Q4 		– Sell
-2
Closed -$8K – 8725
2020
Q3 		$8K Hold
2
– – ﹤0.01% 6898
2020
Q2 		$8K Buy
+2
New +$96 ﹤0.01% 6757

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's KRYS Position: Q1 2026 in Review

Simplex Trading reduced its Krystal Biotech (KRYS) stake by 83% in Q1 2026, selling an estimated $64.7K and leaving 50 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7124.

Simplex Trading first reported a position in KRYS in Q2 2020 and has held it in 9 quarters since. The position peaked at $609K in Q2 2023. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Simplex Trading held 50 shares of Krystal Biotech worth $12.9K as of Q1 2026.
  • Simplex Trading sold 243 Krystal Biotech shares in Q1 2026, an estimated $64.7K.
  • Krystal Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7124 holding.
  • Simplex Trading first reported a position in Krystal Biotech in Q2 2020 and has held it in 9 quarters since.
  • Simplex Trading's Krystal Biotech position peaked at $609K in Q2 2023.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.